Home
    • Plans Blog Contact
    Vynleads, Inc. logo

    Vynleads, Inc.

    VYND
    Last price US$0.41
    Market cap US$7.5m
    12M price change -18.02%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    National Research CorpNRC Industry peer HealthStream IncHSTM Industry peer VEEVA SYSTEMS INCVEEV Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Vynleads, Inc. Overview

    Industry: Health Information Services

    Sector: Healthcare

    Vynleads, Inc. provides health and wellness information to pre-diabetic individuals or type 2 diabetes sufferers primarily in the United States. It offers Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet, as well as nutritional information. The company also sells nutritional supplements; and monthly subscriptions to proprietary newsletter that covers a range of healthy living-related topics. It sells its products online through constitutionalhealth.com, wearedwd.com, and dwdprotocol.com. The company was incorporated in 2015 and is headquartered in Rock Hill, South Carolina. Vynleads, Inc. provides health and wellness information to pre-diabetic individuals or type 2 diabetes sufferers primarily in the United States. It offers Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet, as well as nutritional informa Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Vynleads, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jun 16, 2026

    Quarterly result summary

    Latest company-filed earnings material is available for source review.

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    SEC filing Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing ANNUAL REPORT Mar 31, 2026 SEC filing FORM 10-Q Nov 12, 2025 SEC filing FORM 10-Q Aug 13, 2025 SEC filing FORM 10-Q May 12, 2025 SEC filing ANNUAL REPORT Mar 24, 2025 SEC filing FORM 10-Q Nov 14, 2024 SEC filing FORM 10-Q Aug 14, 2024

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 1.00/5
    Vynleads, Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Health Information Services industry , National Research Corp , HealthStream Inc , VEEVA SYSTEMS INC are companies with high ratings.

    Return on Equity

    Score 1.74/5
    Vynleads, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Vynleads, In... VYND US$7.5m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 0.06/5
    Vynleads, Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Vynleads, In... VYND US$7.5m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Health Information Services industry , National Research Corp , HealthStream Inc , VEEVA SYSTEMS INC are companies with high ratings.

    Leverage

    Score 3.00/5
    Vynleads, Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Vynleads, In... VYND US$7.5m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Vynleads, Inc. logo

    Vynleads, Inc.

    US$0.41

    US$7.5m

    0.00%

    -18.02%